4.7 Article

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 206, Issue 7, Pages 1495-1503

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20090681

Keywords

-

Funding

  1. Ligue Nationale contre le Cancer (Equipe labelisee La Ligue)
  2. Agence Nationale de la Recherche
  3. Institut National de la Sante et de la Recherche Medicale
  4. Centre National de la Recherche Scientifique
  5. Ministere de l'Enseignement Superieur et de la Recherche
  6. Associazione Italiana per la Ricerca sul Cancro
  7. Istituto Superiore di Sanita
  8. Ministero della Sanita
  9. Ministero dell'Istruzione
  10. dell'Universita e della Ricerca Scientifica e Tecnologica

Ask authors/readers for more resources

Cancer development is often associated with the lack of specific and efficient recognition of tumor cells by the immune system. Natural killer (NK) cells are lymphocytes of the innate immune system that participate in the elimination of tumors. We report the identification of a tumor cell surface molecule that binds NKp30, a human receptor which triggers antitumor NK cell cytotoxicity and cytokine secretion. This previously unannotated gene belongs to the B7 family and, hence, was designated B7-H6. B7-H6 triggers NKp30-mediated activation of human NK cells. B7-H6 was not detected in normal human tissues but was expressed on human tumor cells, emphasizing that the expression of stress-induced self-molecules associated with cell transformation serves as a mode of cell recognition in innate immunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available